Skip to main content
AUTOBIO DIAGNOSTICS CO., LTD logo

AUTOBIO DIAGNOSTICS CO., LTD — Investor Relations & Filings

Ticker · 603658 ISIN · CNE100002GC4 LEI · 300300HTZSCUCA32U369 Shanghai Stock Exchange Manufacturing
Open in API
Filings indexed 1,291 across all filing types
Latest filing 2020-04-28 Interim / Quarterly Rep…
Country CN China
Listing Shanghai Stock Exchange 603658

About AUTOBIO DIAGNOSTICS CO., LTD

https://en.autobio.com.cn/

Autobio Diagnostics Co., Ltd. specializes in the research, development, manufacturing, and distribution of comprehensive in vitro diagnostic (IVD) solutions. The company offers an extensive portfolio of products across multiple clinical disciplines, including immunoassay, microbiology, and molecular diagnostics. Key offerings include high-throughput chemiluminescence immunoassay (CLIA) systems, enzyme-linked immunosorbent assay (ELISA) kits, and automated microbiology platforms for blood culture and microbial identification. Autobio also provides integrated laboratory automation systems designed to enhance diagnostic efficiency and accuracy. By focusing on technological innovation and quality, the company serves clinical laboratories, hospitals, and medical institutions worldwide, supporting the detection of infectious diseases, oncology markers, and various metabolic disorders.

Recent filings

Filing Released Lang Actions
2020年第一季度报告
Interim / Quarterly Report Classification · 95% confidence The document is titled '2020 年第一季度报告' which translates to '2020 First Quarter Report'. It contains detailed financial data including consolidated balance sheets, profit and loss statements, cash flow statements, and notes on financial performance for the first quarter of 2020. The report is unaudited as stated in the text. The length of the document is about 15,000 characters, indicating it is a full report rather than a brief announcement. The content includes comprehensive financial statements and analysis for a period shorter than a full fiscal year, specifically a quarter. Therefore, this document fits the definition of an Interim / Quarterly Report (IR). Q1 2020
2020-04-28 Chinese
关于召开2019年年度股东大会的通知
AGM Information Classification · 95% confidence The document is a notice about the convening of the 2019 Annual General Meeting (AGM) of Zhengzhou Antu Bioengineering Co., Ltd. It includes details about the meeting date, voting methods, agenda items to be discussed and voted on, and instructions for shareholders. It does not contain the actual annual report or financial statements but rather the announcement and procedural information for the AGM. The document length is 3391 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, it fits the category of AGM Information (AGM-R).
2020-04-28 Chinese
关于向控股股东借款暨关联交易的公告
Capital/Financing Update Classification · 95% confidence The document is an announcement regarding a related party transaction where the company's controlling shareholder plans to provide a loan to the company and its subsidiaries. It details the loan amount, terms, related party relationships, pricing policy, and approval procedures. The document is a formal disclosure of a financing-related transaction involving the controlling shareholder, which fits the category of Capital/Financing Update (CAP). The document is not a full financial report, audit, or earnings release, nor is it a voting result or management change announcement. It is a specific update on financing activities and related party loans.
2020-04-28 Chinese
关于会计政策变更的公告
Regulatory Filings Classification · 95% confidence The document is an announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding changes in accounting policies. It references specific accounting standards and regulations issued by the Ministry of Finance in China, including new revenue recognition standards and other accounting standards updates. The document details the nature of the accounting policy changes, their impact (or lack thereof) on financial results, and the approval process by the board and supervisory committee. It does not contain actual financial statements or comprehensive financial data but rather explains the policy changes and their rationale. The document length is 3278 characters, which is relatively short and consistent with an announcement rather than a full report. This fits the profile of a Regulatory Filing (RNS) as it is a regulatory announcement about accounting policy changes without substantive financial data or full report content.
2020-04-28 Chinese
关于对全资子公司提供担保预计的公告
Capital/Financing Update Classification · 95% confidence The document is a formal announcement from Zhengzhou Antu Biological Engineering Co., Ltd. regarding the provision of guarantees to its wholly-owned subsidiaries. It details the guarantee amounts, the subsidiaries involved, their financial status, and the board's opinions. The document includes no financial statements or comprehensive financial performance data but focuses on a specific corporate action related to financing support via guarantees. It is not an annual or interim report, audit report, or earnings release. It is not a call transcript or presentation. The document is an announcement about a capital-related guarantee activity requiring shareholder approval, which fits best under Capital/Financing Update (CAP). The document length is under 5,000 characters and contains substantive information about the guarantee, not just a notice of report publication or certification. Therefore, the classification is CAP with high confidence.
2020-04-28 Chinese
第三届监事会第十次会议决议公告
Declaration of Voting Results & Voting Rights Announcements Classification · 95% confidence The document is a resolution announcement from the Supervisory Board of Zhengzhou Antu Bioengineering Co., Ltd. It details the meeting date, attendance, and voting results on various agenda items including the 2019 Supervisory Board Work Report, 2019 Financial Final Accounts Report, 2020 Financial Budget Report, profit distribution plan, and other related reports. The document repeatedly states that these items need to be submitted to the 2019 Annual General Meeting for approval. The document is not the actual annual report or financial statements but a meeting resolution announcement. It also references that detailed reports are disclosed on the Shanghai Stock Exchange website, indicating this document is a formal announcement of meeting resolutions rather than the reports themselves. The document length is about 2430 characters, which is relatively short and consistent with an announcement rather than a full report. Therefore, this document fits best into the category of Declaration of Voting Results & Voting Rights Announcements (DVA).
2020-04-28 Chinese

Browse filings by year

11 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.